Ntses Roj vs Liposomal Omega-3: Ib qho Bioavailability thiab Formulation Comparison

Rau cov neeg tswj xyuas kev yuav khoom thiab pab pawg tsim cov khoom tsim omega-3, kev xaiv ntawm cov roj ntses cov pa thiabliposomal omega-3 hmoovtsis yog ib qho teeb meem ntawm tus nqi ib kilogram xwb- nws yog qhov kev txiav txim siab ncaj qha cuam tshuam rau bioavailability, oxidative stability, sensory performance, thiab formulation elasticity. Liposomal omega-3 hmoov muaj lwm txoj kev xa khoom rau kev hais txog ntau qhov kev sib tw ntev ntev uas cuam tshuam nrog cov roj ntses ib txwm muaj, suav nrog kev ua haujlwm tsis txaus, oxidation sai, thiab tsis hnov ​​​​tsw tsw. Kev nkag siab txog kev sib txawv ntawm ob hom no yog qhov tseem ceeb rau kev txiav txim siab txog kev paub txog kev tsim khoom uas ua raws li cov khoom muag thiab cov neeg siv khoom xav tau.

 

 

Hauv cov qauv nas, phospholipid liposomes tau ua tiav kwv yees li 98% ntawm plab hnyuv fatty acid nqus piv nrog kwv yees li 73% rau cov roj ntses nyob rau hauv cov kev sim zoo tib yam.

Liposomal omega-3 hmoov muab kev tiv thaiv zoo tiv thaiv oxidation-encapsulation hauv phospholipid bilayers txo cov pa oxygen thiab txo qis kev tsim cov khoom lag luam oxidation tsis haum rau cov ntxhiab tsw ntses.

Qhov feem pua ​​​​ntawm DHA hauv cov qog ntshav tau nce siab dua tom qab liposome noj (78%) piv rau cov roj ntses (47%), qhia tau tias muaj txiaj ntsig zoo dua ntawm cov roj ntsha tseem ceeb no.

Liposomal formulations muab cov qauv yooj yim tshaj plaws - hom hmoov ua kom muaj kev sib koom ua ke rau hauv cov dej ntshiab, cov hmoov tsis muaj protein ntau, thiab lwm yam kev siv uas cov roj ntses ua rau muaj teeb meem.

Rau cov neeg yuav khoom B2B, cov qauv ntsuas tseem ceeb suav nrog kev tswj oxidation (peroxide tus nqi, p-anisidine tus nqi), encapsulation efficiency, phospholipid zoo, thiab batch- cov ntaub ntawv txheeb xyuas tshwj xeeb.

 

 

Qhov sib txawv ntawm cov roj ntses thiab liposomal omega -3 pib ntawm qib molecular. Pa roj ntses muaj omega-3 fatty acids esterified li triacylglycerols (TAG) - peb fatty acid chains txuas rau glycerol qaum. Hauv daim ntawv no, EPA thiab DHA yuav tsum tau emulsified los ntawm cov kua tsib ntsev hauv txoj hnyuv thiab hydrolyzed los ntawm pancreatic lipase ua ntej nqus tau.

Liposomal omega-3 hmoov, los ntawm qhov sib txawv, encapsulates EPA thiab DHA nyob rau hauv phospholipid bilayers -microscopic vesicles uas structurally mimic tib neeg cell membranes. Phospholipids yog lub ntuj tsim cov txheej txheem ntawm cov cell membranes, thiab lawv tau txais kev lees paub tias yog cov khoom noj khoom haus zoo tshaj plaws rau cov saw ntev polyunsaturated fatty acids.

Cov kev cuam tshuam ntawm structural yog qhov tseem ceeb:

Parameter	Pas Ntses Roj (TAG)	Liposomal Omega-3 Powder (PL)
Daim ntawv tshuaj	Triacylglycerols (TAG)	Phospholipids (PL) nyob rau hauv bilayer vesicles
Absorption mechanism	Yuav tsum tau cov kua tsib ntsev emulsification + pancreatic lipase	Ua kom muaj kev sib cuam tshuam nrog plab hnyuv epithelial membranes
Absorption efficiency (rat qauv)	~73%	~98%
DHA proportions nyob rau hauv lymph	47%	78%

 

 

Qhov tseem ceeb tshaj plaws kev ua tau zoo sib txawv ntawm cov roj ntses thiab liposomal omega -3 yog kev nqus tau zoo. Ntau yam hauv vivo thiab hauv vitro kev tshawb fawb tau pom tias muaj txiaj ntsig zoo tshaj plaws ntawm phospholipid-raws li kev xa khoom.

Tsiaj qauv pov thawj.Hauv kev tshawb fawb keeb kwm, nas tau noj cov roj ntses (TAG-raws li) los yog liposomes ua los ntawm marine phospholipids nrog tib fatty acid profile. Kev nqus cov roj fatty acid hauv nas tau pom zoo los ntawm liposomes (98 ± 1%) piv rau cov roj ntses (73 ± 6%). Qhov feem pua ​​​​DHA hauv cov qog ntshav tau nce siab dua tom qab liposome noj (78%) dua li tom qab noj cov roj ntses (47%). Qhov no txhais tau hais tias liposomal tus me nyuam tsis yog tsuas yog ua rau kom tag nrho nqus tau tab sis kuj nyiam xa DHA{10}} cov roj fatty acid nrog cov txiaj ntsig kev noj qab haus huv ntau tshaj plaws.

Mechanistic piav qhia.Liposomes tiv thaiv omega-3 fatty acids los ntawm degradation thaum lub plab zom mov thiab pab txhawb kev sib cuam tshuam nrog plab hnyuv epithelial daim nyias nyias. Structureing phospholipids liposomes tshwj xeeb nce cov hnyuv bioavailability ntawm fatty acids esterified nyob rau hauv no lipid chav kawm ntawv, xws li DHA, uas ua rau muaj ntau dua incorporation rau cov qog lipids. Liposomes tshwm sim raws li kev xa khoom zoo dua rau txoj hnyuv nqus ntawm qhov ntev -chain polyunsaturated fatty acids dua li TAG. Tsis tas li ntawd, lawv cov kev tiv thaiv rau lipolysis nyob rau hauv cov mob plab tuaj yeem tiv thaiv LC-PUFA thiab muab lub plab ruaj khov.

Txhawb tib neeg pov thawj.Ib qho 2026 randomized soj ntsuam kev sim tshuaj ntsuam xyuas phospholipid-bound omega-3 piv rau tus qauv omega-3 hauv cov neeg mob hypertriglyceridemic. Txawm hais tias qhov nruab nrab ntawm - pab pawg sib txawv hauv kev txo qis triglyceride tsis ncav cuag qhov tseem ceeb hauv txoj kev tshawb fawb no, feem ntau ntawm cov neeg koom hauv pawg phospholipid tau ua tiav cov qib triglyceride tsawg dua lossis sib npaug li 150 mg / dL (36.4%) piv rau pawg qauv (13.6%). Txoj kev tshawb no xaus lus tias tus lej ntau dua cov lus teb thiab cov txiaj ntsig zoo ntawm biochemical tau soj ntsuam nrog phospholipid formulation warrant ntxiv kev tshawb nrhiav. Txawm hais tias txoj kev tshawb fawb tau soj ntsuam phospholipid-bound omega-3 es tsis yog cov hmoov liposomal coj mus muag, nws muab cov pov thawj txhawb nqa rau qhov zoo ntawm phospholipid-based omega-3 kev xa khoom.

Qhov no txhais tau li cas rau kev yuav khoom:Cov roj ntses ib txwm tso siab rau lub cev lub peev xwm los ua emulsify thiab hydrolyze TAGs- cov txheej txheem uas tsis muaj txiaj ntsig, hloov pauv, thiab txaus siab. Liposomal omega-3 bypasses cov teeb meem no los ntawm kev xa cov fatty acids nyob rau hauv ib daim ntawv uas pab txhawb kev sib cuam tshuam nrog cov hnyuv. Rau cov hom phiaj tsom xam qhov zoo tshaj plaws, qhov kev nqus tau zoo no txhais ua kom muaj txiaj ntsig zoo dua thiab txhim kho bioavailability.

 

 

Omega-3 fatty acids yog qhov cuam tshuam rau oxidation vim lawv ntau ob daim ntawv cog lus. Cov roj ntses cov pa yog qhov tsis ruaj khov thiab yuav tsum tau tuav nruj, ntxuav cov nitrogen, thiab ceev faj ntim kom tsis txhob muaj rancidity. Cov khoom lag luam oxidation tsis hloov pauv-aldehydes, ketones, thiab lwm yam khoom siv degradation-yog lub luag haujlwm rau tus yam ntxwv ntses saj thiab tsw uas ua rau cov neeg siv khoom txaus siab.

Liposomal encapsulation daws qhov teeb meem no los ntawm kev tiv thaiv kev tiv thaiv sib txawv. Los ntawm sequestering omega-3 molecules nyob rau hauv phospholipid bilayers, active fatty acids yog shielded los ntawm ncaj qha oxygen raug. Nanoliposomal encapsulation tau pom tias txo cov ntses saj piv rau dawb omega-3 thiab microencapsulated omega-3.

Kev sib piv Sensory.Cov kev tshawb fawb sib piv nanoliposomal omega-3 nrog unencapsulated ntses roj thiab microencapsulated omega-3 nyob rau hauv daim ntawv thov zaub mov tau pom tias liposomal encapsulation ho txhim kho cov yam ntxwv ntawm lub cev. Daim ntawv thov thiab oxidative stability ntawm nanoliposomal omega-3 nyob rau hauv cov zaub mov enrichment pom muaj txiaj ntsig zoo ntawm kev hnov ​​​​qab, uas yog neutralizing cov ntses saj.

Kev xav txog kev ruaj ntseg.Thaum liposomal omega-3 hmoov muaj kev txhim kho oxidative kev ruaj ntseg piv rau cov kua ntses roj, nws yog ib qho tseem ceeb kom paub tias phospholipids lawv tus kheej yog PUFA- nplua nuj thiab tuaj yeem oxidize yog tias tsis muaj zog. Kev ruaj ntseg nyob ntawm phospholipid zoo, cov kab mob antioxidant (xws li, alpha-tocopherol), kev ua haujlwm, thiab ib puag ncig cia.

Qhov no txhais tau li cas rau kev yuav khoom:Rau cov ntawv thov rhiab heev-cov dej ntshiab, cov hmoov tsis muaj ntxhiab, thiab cov khoom noj khoom haus zoo tshaj - qhov tsis hnov ​​tsw ntawm liposomal omega-3 tsis yog khoom kim heev; nws yog qhov yuav tsum tau muaj rau kev lag luam viability. Pa roj ntses, txawm nyob rau hauv daim ntawv microencapsulated, feem ntau tsis ua kom muaj kev ruaj ntseg ntawm cov khoom txee lub neej.

 

 

Lub cev daim ntawv ntawm cov khoom muaj qhov cuam tshuam loj heev rau formulation compatibility.

Ntses rojyog ib cov kua uas yuav tsum tau encapsulation nyob rau hauv softgels, emulsification nrog stabilizers, los yog complex tuav los koom rau hauv qhuav los yog aqueous systems. Nws feem ntau tsis tsim nyog rau cov ntawv thov dej ntshiab vim yog qhov tsis txaus ntseeg ntawm emulsion thiab cov teeb meem ntawm kev hnov ​​​​qab, nyiam oxidize sai hauv cov dej hauv ib puag ncig, thiab tuaj yeem cuam tshuam tsis zoo rau emulsion stability thiab hnov ​​​​zoo hauv cov protein- muaj cov dej haus.

Liposomal omega-3 hmoov muaj superior versatility. Cov hmoov hom tuaj yeem nkag mus rau hauv:

• Cov dej haus ua haujlwm (ntshiab lossis huab) tsis muaj roj sib cais
• Unflavored protein hmoov thiab zaub mov hloov
• Cov khoom ci thiab khoom noj txom ncauj (nrog rau kev txiav txim siab tsim nyog)
• Sachets thiab stick packs kom yooj yim dosing

Rau B2B formulators, liposomal omega-3 hmoov ua rau siab -dose incorporation rau hauv rhiab daim ntaub ntawv xws li unflavored protein hmoov thiab lwm yam khoom noj siv mis nyuj uas tsis muaj kev cuam tshuam rau qhov kawg-neeg siv qhov kev paub.

Qhov no txhais tau li cas rau kev yuav khoom:Cov hmoov hom ntawm liposomal omega-3 ua kom yooj yim khaws cia thiab tuav piv nrog cov kua ntses roj hauv ntau cov txheej txheem tsim, thiab ua kom cov khoom lag luam txhim kho thoob plaws ntau pawg uas tsis tuaj yeem siv tau rau cov kua ntses roj. Qhov kev hloov pauv no txhawb nqa hom kev nthuav dav thiab cov khoom lag luam sib txawv.

 

 

Daim ntawv thov	Pas Ntses Roj	Liposomal Omega-3 Hmoov	Kev xav
Softgel capsules	Tsim nyog	Tshaj - engineering	Tus nqi-sensitive hom; saj raug txwv
Cov dej ntshiab	Tsis haum	Tsim nyog heev	Roj sib cais thiab oxidation teeb meem nrog ntses roj
Unflavored hmoov	Tsis haum	Tsim nyog heev	Sensory neutrality tseem ceeb
Me nyuam mos mis	Txwv tsis pub	Muaj peev xwm tsim nyog	Zero kam rau ua tawm -flavors; nqus tau zoo; yuav tsum muaj kev tswj xyuas qhov tseeb
Khoom noj khoom haus	Txwv tsis pub	Tsim nyog heev	Emulsion stability thiab sensory teeb meem nrog ntses roj
Khoom noj khoom haus hwm tsiaj	Txwv tsis pub	Tsim nyog heev	Qhov ncauj qhov ntswg tseem ceeb; hwm ntu txhawb kev nqis peev
Khoom noj khoom haus fortification	Nruab nrab	Daim ntawv thov - nyob ntawm	Nyob ntawm kev ua haujlwm thiab qhov xav tau ntawm kev xav

 

 

Rau B2B cov neeg yuav khoom ntsuas liposomal omega-3 hmoov piv rau cov roj ntses, cov qauv hauv qab no muab lub hauv paus rau kev paub txog kev txiav txim siab:

1. Bioavailability validation.Thov kev sib piv bioavailability cov ntaub ntawv los ntawm tus neeg muag khoom- qhov zoo tshaj plaws los ntawm kev tshawb fawb vivo qhia txog kev nqus tau zoo ntawm lawv cov qauv tsim tshwj xeeb. Cov ntaub ntawv luam tawm, suav nrog Cansell et al. (2003) rat study and the Sehl et al. (2020) txoj kev tshawb fawb plab hnyuv bioavailability, sawv cev rau hom pov thawj ntawm pawg neeg yuav khoom yuav tsum siv.

2. Oxidation tswj.Ntsuas tus nqi peroxide (POV) thiab p-anisidine tus nqi (p-AV) cov ntaub ntawv. GOED monograph txwv oxidation ntawm PV < 5 mEq/kg roj thiab p-AV < 20. hwm- qib liposomal systems feem ntau tsom PV Tsawg dua lossis sib npaug li 2.0 meq/kg.

3. Encapsulation efficiency thiab to kinetics.Thov encapsulation efficiency cov ntaub ntawv thiab to taub tus nqi (% ib 30, 60, 90 hnub) kom nkag siab txog ntev - lub sij hawm stability.

4. Phospholipid zoo.Lub oxidative stability ntawm liposomal carrier nws tus kheej yog qhov tseem ceeb. Thov cov ntaub ntawv ntawm phospholipid muaj pes tsawg leeg (saturated vs unsaturated), antioxidant system (xws li, alpha-tocopherol), thiab qhov chaw.

5. Kev ua dej num thiab kev tswj cov dej noo.Rau cov qauv hmoov, dej ua haujlwm (aw) yog qhov tseem ceeb ntawm kev ruaj ntseg. Low aw (<0.3) is essential for long-term powder stability.

6. Cov ntaub ntawv txheeb xyuas.Batch-Cov ntawv pov thawj tshwj xeeb ntawm Kev Ntsuam Xyuas (COA) suav nrog tag nrho EPA + DHA cov ntsiab lus, POV, p-AV, hnyav hlau tsom xam, dej dej, thiab cov ntaub ntawv kev nyab xeeb microbiological.

7. Cov ntawv pov thawj thiab ua raws.cGMP, ISO 22000, FSSC 22000, HACCP, Kosher, Halal, Tsis yog -GMO Project Verified.

 

 

Rau B2B tus thawj tswj hwm thiab cov neeg tsim khoom lag luam, kev xaiv ntawm cov roj ntses ib txwm siv thiab liposomal omega-3 hmoov tsis yog kev sib piv tus nqi yooj yim- nws yog qhov kev txiav txim siab uas cuam tshuam ncaj qha rau bioavailability, stability, sensory performance, thiab brand positioning. Cov roj ntses cov pa ib txwm ntsib zoo- cov kev txwv tsis pub muaj: kev nqus tsis zoo, oxidation sai, tsis hnov ​​​​tsw ntses, thiab kev ua kom tsis muaj zog. Liposomal omega-3 hmoov tau pom tias muaj kev nqus tau zoo dua hauv cov qauv ua ntej thiab phospholipid-raws li kev tshawb fawb, txhim kho oxidative stability, txo qis cov ntawv sau ntses, thiab ntau hom hmoov sib xyaw. Los ntawm kev koom tes nrog tus neeg muag khoom pob tshab uas muab cov ntaub ntawv pov thawj bioavailability, cov ntaub ntawv ruaj ntseg, thiab cov ntawv pov thawj tshwj xeeb analytical, cov tuam txhab tuaj yeem xa cov khoom lag luam omega-3 uas ua haujlwm tsis tu ncua thoob plaws txawm tias cov ntawv thov nkag siab tshaj plaws.

 

Cov kauj ruam tom ntej rau koj cov qauv

Feem ntau cov neeg siv khoom pib nrog kev tsav tsheb batch (100-500 g) kom siv tau cov dispersibility, stability, thiab sensory kev ua tau zoo nyob rau hauv lawv cov matrix tshwj xeeb ua ntej scale mus ua lag luam ntau lawm. Batch-specific COA, cov ntaub ntawv ruaj khov, thiab kev qhia kev tsim muaj los txhawb koj cov txheej txheem tsim khoom.

• [Thov cov qauv qauv]- Ntsuam xyuas peb cov qib liposomal omega-3 hmoov (Ntau dua lossis sib npaug li 25% tag nrho omega-3) hauv koj tus kheej cov qauv matrix.
• [Access technical documentation]– Saib xyuas HPLC cov ntaub ntawv ntsuam xyuas, tus nqi peroxide (POV) thiab p-anisidine tus nqi (p-AV) cov ntaub ntawv, dej dej, thiab kev tshawb fawb kev ruaj ntseg.
• [ Sib tham txog kev cai specifications]- Tshawb nrhiav kev cai ntau, qhov loj me me kom zoo, lossis kev xaiv ua.
• [Schedule ib tug formulation kev sab laj]- Ntsib nrog peb pab neeg R&D los hais txog bioavailability, oxidation tswj, los yog daim ntawv thov -cov kev cov nyom tshwj xeeb.

MOQ, lub sijhawm ua haujlwm, thiab tus nqi ntau muaj nyob ntawm qhov kev thov. Rau kev txhawb nqa, kev sib tham txog kev tsim, thiab cov lus hais ntau, hu rau peb pawg neeg ua haujlwm engineering ntawmliu@wellgreenxa.com.

 

Cov ntaub ntawv

1. Cansell, M., Naka, F., & Combe, N. (2003). Marine lipid-raws li liposomes nce hauv vivo FA bioavailability.Lipids, 38(5), 551-559.
2. Cansell, M. (2010). Marine phospholipids ua cov khoom noj khoom haus ntev -chain polyunsaturated fatty acids.Lipid Technology, 22(10), 223-226. 
3. Sehl, A., Couëdelo, L., Vaysse, C., & Cansell, M. (2020). Txoj hnyuv bioavailability ntawm n-3 ntev-chain polyunsaturated fatty acids cuam tshuam los ntawm supramolecular daim ntawv ntawm phospholipids.Khoom noj khoom haus & Muaj nuj nqi, 11(2), 1721-1728. 
4. Amara, S., Gerlei, M., Jeandel, C., et al. (2024). Hauv vitro plab hnyuv plab zom mov ntawm marine roj emulsions thiab liposomal daws: txoj hmoo ntawm LC-PUFAs raws li lipolysis.Khoom noj khoom haus & Muaj nuj nqi, 15(22), 11291-11304. 
5. Rasti, B., Erfanian, A., & Selamat, J. (2017). Novel nanoliposomal encapsulated omega-3 fatty acids thiab lawv cov kev siv hauv cov zaub mov.Khoom noj khoom haus Chemistry, 230, 690-696. 
6. Ntiaj teb no lub koom haum rau EPA thiab DHA Omega-3s (GOED). GOED Voluntary Monograph Version 7.1. Ntiaj teb no Cov Qauv Zoo rau EPA thiab DHA Omega-3 Roj.